ArticleBMC biotechnology2025
Production of the Bakırköy strain of sheeppox vaccine virus in spinner flasks using an alternative method with Cytodex 1 microcarriers on Vero cells.
Article in BMC biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advantages and research progress of three-dimensional culture systems for lung cancer drug screening (Review).Oncology letters · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSheeppox (SPP) is a highly contagious viral disease that causes significant morbidity and economic losses in small ruminants. Effective control relies on widespread vaccination, yet conventional production methods that utilize monolayer cultures are limited in scalability, making it difficult to meet large-scale vaccine demands. This study aimed to determine optimal and scalable conditions for producing the Bakırköy strain of the sheeppox virus (SPPV) vaccine using Cytodex 1 microcarriers (MCs) in spinner flasks with Vero cells.
methodsVero cells were propagated in serum-supplemented medium, and cell growth, viability, glucose utilization, and metabolite accumulation were monitored during the expansion phase. In both systems, cells were infected with the Bakırköy strain of SPPV vaccine at multiplicities of infection (MOIs) of 0.1 and 1, and viral titers, cell viability, and metabolite levels were evaluated post-infection.
resultsSpinner flask cultures supported higher cell densities and maintained cell viability longer than T-flask cultures. Virus replication was more efficient under dynamic conditions, resulting in higher peak titers and an extended productive phase. Metabolite accumulation (lactate and ammonia) did not adversely affect virus yield until they reached critical thresholds.
conclusionsThese findings highlight the importance of metabolite control in optimizing SPPV vaccine production. They also demonstrate that Cytodex 1 microcarrier (MC)-based spinner flask cultures offer a robust and scalable alternative to conventional methods. This approach enables prolonged production, higher viral yields, and greater potential for large-scale vaccine manufacturing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.